Report overview
An in silico clinical trial, also known as a virtual clinical trial, is an individualized computer simulation used in the development or regulatory evaluation of a medicinal product, device, or intervention. While completely simulated clinical trials are not feasible with current technology and understanding of biology, its development would be expected to have major benefits over current in vivo clinical trials, and research on it is being pursued.
This report aims to provide a comprehensive presentation of the global market for In Silico Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Silico Clinical Trials. This report contains market size and forecasts of In Silico Clinical Trials in global, including the following market information:
Global In Silico Clinical Trials Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global In Silico Clinical Trials market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Phase I Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of In Silico Clinical Trials include Certara, Inc., Novadiscovery Sas, Insilico Medicine, Inc., Dassault Systemes SE, GNS Healthcare Inc., The AnyLogic Company, InSilicoTrials, Immunetrics Inc. and Nuventra Pharma Sciences, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the In Silico Clinical Trials companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global In Silico Clinical Trials Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global In Silico Clinical Trials Market Segment Percentages, by Type, 2022 (%)
Phase I
Phase II
Phase III
Phase IV
Global In Silico Clinical Trials Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global In Silico Clinical Trials Market Segment Percentages, by Application, 2022 (%)
Oncology
Infectious Disease
Hematology
Cardiology
Dermatology
Neurology
Diabetes
Others
Global In Silico Clinical Trials Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global In Silico Clinical Trials Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies In Silico Clinical Trials revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies In Silico Clinical Trials revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Certara, Inc.
Novadiscovery Sas
Insilico Medicine, Inc.
Dassault Systemes SE
GNS Healthcare Inc.
The AnyLogic Company
InSilicoTrials
Immunetrics Inc.
Nuventra Pharma Sciences
Abzena Ltd.
Siemens
Outline of Major Chapters:
Chapter 1: Introduces the definition of In Silico Clinical Trials, market overview.
Chapter 2: Global In Silico Clinical Trials market size in revenue.
Chapter 3: Detailed analysis of In Silico Clinical Trials company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of In Silico Clinical Trials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
